Announcement on behalf of major subsidiary, Yung Shin Pharm. Ind. Co., Ltd. the Board meeting on removal of the non-compete clause for President

 Announcement on behalf of major subsidiary,
Yung Shin Pharm. Ind. Co., Ltd. the Board meeting
on removal of the non-compete clause for President

1.Date of the board of directors resolution:2022/08/09
2.Name and title of the managerial officer with permission to engage in
  competitive conduct:President Ling-Chin Lee
3.Items of competitive conduct in which the officer is permitted to engage:
 Investing in or managing a third party operating in a scope of business
 similar to that of the Company and acting as a Director or Managerial
 officer.
4.Period of permission to engage in the competitive conduct:
 for the duration of serving as a President of the Company.
5.Circumstances of the resolution (please describe the results of voting in
accordance with Article 32 of the Company Act):
 except for President Ling-Chin Lee is not permitted to participate in
 voting, the other Directors present agreed to remove the non-compete
 clause of President Ling-Chin Lee.
6.If the permitted competitive conduct belongs to the operator of a mainland
China area enterprise, the name and title of the managerial officer
(if it is not the operator of a mainland China area enterprise, please enter
"N/A" below):N/A
7.Company name of the mainland China area enterprise and the officer's
position in the enterprise:N/A
8.Address of the mainland China area enterprise:N/A
9.Operations of the mainland China area enterprise:N/A
10.Impact on the company's finance and business:no major impact
11.If the managerial officer has invested in the mainland China area
enterprise, the monetary amount of the investment and the officer's
shareholding ratio:none
12.Any other matters that need to be specified:none